The South African variant shows more spike protein mutations than the UK variant, which might allow the virus to escape the immune protection provided by vaccination or prior infection.
South Africa, which has yet to receive its first coronavirus vaccine, has been promised nine million doses by Johnson & Johnson, the Business Day newspaper reported, citing a health ministry spokeswoman.